Shares in Geo Exploration jumped as much as 15% after the AIM-listed natural resources group announced it had repaid in full an interest-free loan from chief executive Omar Ahmad, leaving the company debt-free as drilling begins at its flagship Juno project.
The $270,000 loan was provided in July 2024 at a critical moment for the business, giving management the stability to press ahead with operational plans.
EnWave Corp (TSX-V:ENW, OTC:NWVCF) announced that it has entered into an Equipment Purchase Agreement with BranchOut Foods for the sale of a 120kW Radiant Energy Vacuum (REV) dehydration machine.
The new machine, destined for BranchOut Foods’ production facility in Peru, marks the company’s fourth large-scale REV installation.
American Resources Corp (NASDAQ:AREC) announced that its ReElement Technologies subsidiary has signed a memorandum of understanding (MOU) with POSCO International Corporation.
The company said the agreement aims to strengthen the rare-earth supply chain and explore cooperation on establishing an integrated rare-earth and permanent-magnet production complex in the US.
Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF) announced that its investee company, Hivello Holdings, has entered into a partnership with Spheron Network to enhance the earning potential of Hivello users while supporting Spheron’s goal of building the world’s largest community-powered data center.
Spheron offers enterprise-level GPU compute services that can be accessed through one-click transactions. The collaboration allows Hivello users, who supply idle computing power, to contribute to Spheron’s network with minimal setup.
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) announced that it has signed a letter of intent (LOI) with Collective Metals (CSE: COMT), in which Collective Metals will be granted the option to acquire a 75% interest in the 4,002-hectare Rocas Project in Saskatchewan’s eastern Athabasca Basin region.
The uranium exploration company said to receive its 75% interest, Collective Metals must pay C$225,000 in cash, issue C$725,000 in Collective Metals shares, and incur C$4.5 million worth of exploration expenditures over three years.
Medicus Pharma (NASDAQ:MDCX) announced Thursday that it has entered into a financing agreement with Yorkville Advisors Global, through its fund YA II PL, Ltd., raising $8 million in non-dilutive debenture financing.
The financing is structured as a one-year debenture bearing 8% annual interest, repayable in monthly installments with final payment due at maturity.
Zacatecas Silver Corp. (TSX-V:ZAC, OTC:ZCTSF) reported that it has increased the size of its previously announced private placement financing from 41,666,666 company units to 62,500,000 units, at a price of C$0.06 per unit, for gross proceeds of up to $3.75 million.
The precious metals projects developer said proceeds of the offering will be used to fund a drilling campaign on the Zacatecas Silver Project, strategic initiatives, and working capital purposes.
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has been awarded a grant of up to $11.4 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to advance its work on novel therapies for opioid use disorder (OUD).
The company said the five-year UG3/UH3 grant will support optimization and early-stage development of atai’s 5-HT2A/2C receptor agonists, which are designed to retain therapeutic activity without hallucinogenic effects.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced that BUZZ High Performance Computing (BUZZ HPC), its wholly owned subsidiary, has acquired a 7.2-megawatt (MW) data centre site in the Greater Toronto Area (GTA).
The multinational digital infrastructure company said the site will form the foundation of a new Tier III+ data centre built specifically for artificial intelligence (AI) workloads.
Mkango Resources Ltd (AIM:MKA, TSX-V:MKA, OTC:MKNGF) shares strengthened on Thursday after it secured funds for its recycling venture.
The AIM-quoted company raised £3 million through a private placement to accelerate the scale-up of its rare earth magnet recycling and manufacturing operations.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) told investors that construction and preparatory work at the Galactica project in Colorado remains on track for first helium production by December.
Site preparations have been largely completed, including surveying of gathering lines, road access and the plant site. All required construction permits have been secured, Helium One said in a statement.
Iofina PLC (AIM:IOF, OTC:IOFNF) has said it remains well-positioned to press ahead with expansion after posting record half-year revenues and higher iodine output.
The AIM-listed group, which extracts iodine from waste brine water produced by the oil industry, reported sales of $29.2 million in the first six months of 2025, up 12% on a year earlier.
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) told investors that hydraulic fracture stimulation at the Dubhe-1 well is expected to begin in the week commencing 29 September.
The well, located within the Ahpun project on Alaska's North Slope, has completed drilling and casing operations and is now ready for the final stages of completion.
Lithium Universe Ltd (ASX:LU7, OTC:LUVSF) has reported another breakthrough in its solar recycling program, achieving near-Britannia silver purity from its proprietary Jet Electrochemical Silver Extraction (JESE) process in just five minutes.
The company said the results mark a major proof-of-concept milestone, underscoring the technology’s potential to deliver both commercial and environmental benefits in recovering valuable metals from end-of-life solar panels.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has reported further positive clinical data from its Phase 1b trial of azer-cel, an allogeneic, off-the-shelf CD19 CAR T therapy, in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
The overall response rate (ORR) —the proportion of patients achieving either a complete or partial response — has now increased to 81% following two new partial responses and a patient transitioning from partial to complete response at their 90-day scan. This is up from the 79% rate reported in August and brings total responses to 13 out of 16 patients, comprising seven complete responses (CRs) and six partial responses (PRs).
Investment research house Edison Group has set a valuation of A$66.7 million (6.1 cents per share) for Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF), framing the company’s reset around anti-VISTA checkpoint candidate HMBD-002 as the key to a potential re-rating.
With Percheron’s cash position of A$10.2 million and full Phase I data due later in the year ahead of Phase II in 2026, Edison analysts Jyoti Prakash and Arron Aatkar see a defined catalyst path — albeit with the execution and target-validation risks typical of early clinical programmes.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) has raised A$25.1 million through a strongly supported placement at A$0.05 per share, drawing commitments from global institutions and high-net-worth investors. The placement included cornerstone support of A$7.75 million from prominent local and international groups, while directors also subscribed for A$200,000.
The raise fully funds the company’s medium-term work programs and strengthens its balance sheet ahead of a proposed NASDAQ listing.
American Uranium Ltd (ASX:AMU, OTC:GTRIF) will begin hydrogeologic testing and resource expansion drilling at its Lo Herma In-Situ Recovery (ISR) Uranium Project in Wyoming’s Southern Powder River Basin during the fourth quarter of calendar year 2025.
The company confirmed that both programs are expected to be incorporated into an updated Mineral Resource Estimate (MRE) in the first quarter of 2026, with findings to also inform a Scoping Study later in the year.
Environmental approval from the Western Australia Government’s Department of Mines, Petroleum and Exploration for its Well Drilling Environment Plan, has cleared the way for Buru Energy Ltd (ASX:BRU, OTC:BRNGF)’s 2026 Rafael resource appraisal campaign, a key step in advancing the 100% owned Rafael Gas Project in exploration permit EP 428.
Drilling is planned to begin in the second quarter of 2026, subject to completion of the upstream funding partner selection process. A Final Investment Decision is scheduled for the second half of 2026, with first cashflows projected from 2028.
Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) has confirmed that the rights under its Renounceable Rights Issue, announced on September 12, 2025, will start trading today on the Australian Securities Exchange under the code IXRR.
The offer is renounceable, allowing eligible shareholders to renounce (sell) some or all of their rights and trade them on ASX if they choose not to take up their entitlement. Trading of rights will run from September 18, 2025, until October 2, 2025, though there is no guarantee an active market will develop.
Race Oncology Ltd (ASX:RAC, OTC:RAONF) invites shareholders and potential investors to attend a special online investor webinar to discuss the company’s recently lodged composition of matter patent application.
